Vitamin C Gummies With Rosehips And Bioflavonoids Orange Flavored
Sundown's Vitamin C Gummies With Rosehips And Bioflavonoids Orange Flavored is an 'Other Combinations' supplement, achieving an N+ Score of 79 and a grade of B-. This product contains 5 ingredients, notably providing Vitamin C (250 mg) at a clinically studied dosage. It also includes a 25 mg proprietary blend with Rosehips and Bioflavonoids, though the specific amounts of individual components in this blend are not disclosed. The gummy format may appeal to those who prefer an alternative to pills. This supplement may support immune function and antioxidant processes.
About This Product
Vitamin C Gummies With Rosehips And Bioflavonoids Orange Flavored by Sundown is a vitamins & minerals supplement containing 5 active ingredients. It has earned an N+ Score of 79/100 (Grade B-).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Vitamin C.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 15.000 Calorie(s) | N/A |
| Vitamin C | 250.000 mg | Optimal |
| Total Carbohydrates | 4.000 Gram(s) | N/A |
| Sodium | 20.000 mg | N/A |
| Proprietary Blend | 25.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.